Seven Pharma Chile Spa., Pharmaceutical Import Profile — Chile (DGFT 2022–2026)

Name: Seven Pharma Chile Spa., Pharmaceutical Import Records from India — 6 Products, $2.0M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Seven Pharma Chile Spa., — Pharmaceutical Importer Profile (2026) | 6 Products, $2.0M Trade | TransData Nexus

Seven Pharma Chile Spa.,

Pharmaceutical Importer · Chile · Respiratory Focus · $2.0M Total Trade · DGFT Verified

Seven Pharma Chile Spa., is a pharmaceutical importer based in Chile with a total trade value of $2.0M across 6 products in 5 therapeutic categories. Based on 74 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Seven Pharma Chile Spa., sources from 1 verified Indian supplier, with Baroque Pharmaceuticals Private Limited accounting for 100.0% of imports.

Seven Pharma Chile Spa., — Import Portfolio & Supplier Network

Seven Pharma Chile Spa., import network — 6 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Seven Pharma Chile Spa.,?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Baroque Pharmaceuticals Private Limited	$558.6K	31	100.0%

Seven Pharma Chile Spa., sources from 1 verified Indian supplier across 11 distinct formulations. The sourcing is highly concentrated — Baroque Pharmaceuticals Private Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

Formulation	Value	Ships
Ambroxol hydrochloride syrup 30 MG/5 ML	$102.1K	5
Lactulose solution	$100.0K	2
Ibuprofen oral	$71.7K	2
Bromhexine hydrochloride syrup 4MG/5ML	$59.1K	4
Bromhexine hydrochloride syrup 4MG/5ML,batch no-g013332,g013333,g013347,g013348,g013349,g013350,g013351	$50.0K	1
Ibuprofen oral suspension	$36.5K	1
Ambroxol hydrochloride syrup 30 MG/5	$36.0K	3
Bromhexine hydrochloride syrup	$32.6K	3
Moxetero	$31.3K	5
Bromhexine hydrochloride syrup 8MG/5ML	$29.6K	4
Ambroxol hydrochloride syrup 30 MG/5 ML, batch no.: g013228 ,mfg.dt.: 08/ 2023,exp.dt.: 07/	$9.8K	1

Import Portfolio — Top 6 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Salmeterol	Respiratory	$1.3M	41	1.8%	14
2	Bromhexine	Respiratory & OTC	$183.4K	12	1.1%	13
3	Fluorouracil	Oncology	$172.3K	8	1.4%	14
4	Ambroxol	Respiratory & OTC	$147.9K	9	1.0%	14
5	Indomethacin	Analgesics & Antipyretics	$100.0K	2	1.1%	7
6	Lactulose	Gastrointestinal	$100.0K	2	0.7%	12

Seven Pharma Chile Spa., imports 6 pharmaceutical products across 5 categories into Chile totaling $2.0M.

Seven Pharma Chile Spa., — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Seven Pharma Chile Spa. is a pharmaceutical importer and distributor headquartered in Santiago, Chile. Established on March 13, 2015, the company specializes in the wholesale distribution of pharmaceutical and medicinal products. As a subsidiary of the global pharmaceutical group Hetero, Seven Pharma Chile Spa. plays a pivotal role in enhancing the accessibility and affordability of high-quality medications across the Latin American region.

The company's primary operations involve importing finished pharmaceutical formulations from India, focusing on a diverse range of therapeutic categories. This strategic sourcing approach enables Seven Pharma Chile Spa. to offer a comprehensive portfolio of medications, catering to various medical needs within the Chilean market.

2Distribution Network

Seven Pharma Chile Spa. operates from its main facility located at Til Til 2640, Module S5, Macul, Santiago, Chile. The company maintains a robust distribution network that ensures efficient delivery of pharmaceutical products to various institutions, including hospitals, clinics, pharmacies, and government agencies. By adhering to local regulatory standards, Seven Pharma Chile Spa. guarantees the timely and safe distribution of medications throughout Chile.

3Industry Role

In Chile's pharmaceutical supply chain, Seven Pharma Chile Spa. functions as a primary wholesaler and importer. By sourcing finished pharmaceutical formulations from India, the company bridges the gap between international manufacturers and the local market, ensuring the availability of essential medications. This role is crucial in maintaining a steady supply of pharmaceutical products, thereby supporting the healthcare infrastructure in Chile.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Seven Pharma Chile Spa.,

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Seven Pharma Chile Spa. demonstrates a high degree of supplier concentration, with all its pharmaceutical imports originating from a single Indian supplier, Baroque Pharmaceuticals Private Limited. This exclusive sourcing strategy accounts for a total import value of $559,000 across 31 shipments, representing 100% of the company's pharmaceutical imports from India.

While this single-source dependency may present risks related to supply chain disruptions, it also indicates a strategic partnership that could lead to favorable terms and consistent product quality. The stability of this relationship is evidenced by the consistent volume of imports over the years, suggesting a reliable and mutually beneficial arrangement.

2Supply Chain Resilience

The resilience of Seven Pharma Chile Spa.'s supply chain is closely tied to its exclusive relationship with Baroque Pharmaceuticals Private Limited. This singular sourcing approach may expose the company to risks associated with geopolitical events, regulatory changes, or operational challenges within the supplier's domain. However, the consistent import volumes and the strategic nature of the partnership imply that both parties have established mechanisms to mitigate potential disruptions. The company's adherence to local regulatory standards further enhances the reliability of its supply chain operations.

Importing Pharmaceuticals into Chile — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Chile

1Regulatory Authority & Framework

In Chile, the regulation of pharmaceutical products, including their importation, is overseen by the Public Health Institute (Instituto de Salud Pública, ISP), an autonomous public service under the Ministry of Health (MINSAL). (britcham.cl) The ISP is responsible for defining and controlling regulations governing the import, clearance, export, production, and manufacturing of pharmaceutical products and medical devices. The Ministry of Health sets the overarching policies and standards for the pharmaceutical sector, ensuring that all activities comply with national health objectives.

2Import Licensing & GMP

Importers of pharmaceutical products into Chile must obtain authorization from the ISP. This process involves submitting detailed information about the pharmaceutical products, including their composition, intended use, packaging, labeling, and manufacturer information. Additionally, the ISP requires that imported pharmaceutical products adhere to Good Manufacturing Practice (GMP) standards recognized by international bodies such as the European Union (EU) and the World Health Organization (WHO). Importers must ensure that their suppliers possess valid GMP certificates to facilitate the importation process.

Quality & Labeling

Seven Pharma Chile Spa., — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Seven Pharma Chile Spa. focuses on importing pharmaceutical products across several therapeutic categories, including respiratory, oncology, and over-the-counter (OTC) medications. This strategic selection aligns with the prevalent health concerns in Chile, such as respiratory diseases and cancer, thereby addressing significant market demands. By offering a diverse product portfolio, the company aims to meet the varied healthcare needs of the Chilean population.

2Sourcing Profile

The company's sourcing strategy emphasizes the importation of generic drug formulations, primarily sourced from India. This approach allows Seven Pharma Chile Spa. to provide cost-effective alternatives to branded medications, making essential treatments more accessible to a broader segment of the population. The focus on finished pharmaceutical formulations ensures that the company can offer ready-to-use products that meet local regulatory standards.

3Market Positioning

Based on its product mix, Seven Pharma Chile Spa. serves multiple segments of the Chilean pharmaceutical market, including retail pharmacies, hospitals, government tenders, and wholesale distribution. By catering to these diverse sectors, the company plays a crucial role in ensuring the availability of essential medications across the country. Its strategic sourcing and distribution capabilities enable it to meet the needs of various healthcare providers and consumers.

Seller's Guide — How to Become a Supplier to Seven Pharma Chile Spa.,

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to collaborate with Seven Pharma Chile Spa., given the company's established sourcing pattern and its focus on importing finished pharmaceutical formulations. Potential suppliers should assess the therapeutic categories that align with the company's current portfolio and identify any gaps that could be addressed. Building a relationship with Seven Pharma Chile Spa. could provide access to the Chilean market and contribute to the company's mission of enhancing healthcare accessibility.

2Requirements & Qualifications

Indian exporters seeking to supply Seven Pharma Chile Spa. must ensure that their products comply with Chilean regulatory standards, including obtaining necessary approvals from the ISP. Products should adhere to GMP standards recognized by international bodies such as the EU and WHO. Additionally, exporters must provide labeling in Spanish and ensure that their products meet all quality and stability requirements set forth by Chilean authorities.

3How to Approach

Frequently Asked Questions — Seven Pharma Chile Spa.,

What products does Seven Pharma Chile Spa., import from India?

Seven Pharma Chile Spa., imports 6 pharmaceutical products across 5 categories. Top imports: Salmeterol ($1.3M), Bromhexine ($183.4K), Fluorouracil ($172.3K), Ambroxol ($147.9K), Indomethacin ($100.0K).

Who supplies pharmaceuticals to Seven Pharma Chile Spa., from India?

Seven Pharma Chile Spa., sources from 1 verified Indian suppliers. The primary supplier is Baroque Pharmaceuticals Private Limited (100.0% of imports, $558.6K).

What is Seven Pharma Chile Spa.,'s total pharmaceutical import value?

Seven Pharma Chile Spa.,'s total pharmaceutical import value from India is $2.0M, based on 74 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Seven Pharma Chile Spa., focus on?

Seven Pharma Chile Spa., imports across 5 categories. The largest: Respiratory (65.6%), Respiratory & OTC (16.2%), Oncology (8.4%).

Get Full Seven Pharma Chile Spa., Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.